All In Solutions California, a premier addiction treatment center, has reinforced its commitment to equipping clients with comprehensive relapse prevention tools designed to support sustainable ...

New Reno behavioral health practice provides structured substance use evaluations, DUI-related support, counseling, and ...

A 2015 study comparing schizophrenia patients who received oral or injectable antipsychotic medications found no difference in relapse rates between the groups. Now, a follow-up study published August ...

Mental health and addiction recovery experts emphasize that relapse prevention requires a personalized, written plan combining trigger identification, coping strategies, and support systems. Recent ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that ...

Even as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a significant limitation: many patients, including those whose cancer goes into ...

NEW YORK (Reuters Health) - A treatment program incorporating mindfulness meditation is better over the long term than traditional approaches at preventing relapses of drug and alcohol abuse, ...

Please provide your email address to receive an email when new articles are posted on . Clozapine and second-generation long-acting formulations of certain antipsychotics decreased risk for ...

The authors reviewed the literature to identify high-quality studies (observational and controlled) of ANCA-associated vasculitis that included a predetermined target dose of steroids at the end of ...

Thalidomide demonstrated superior efficacy in preventing the relapse of immunoglobulin G4–related disease (IgG4-RD) during a 12-month follow-up period in a placebo-controlled trial. The treatment ...